Cash flow Universal Health Services, Inc.

Equities

UHS

US9139031002

Healthcare Facilities & Services

Delayed Nyse Other stock markets 03:55:21 2024-12-02 pm EST			5-day change	1st Jan Change
200.99 ^USD	-1.96%		+0.91%	+31.87%

Nov. 26	TD Cowen Adjusts Price Target on Universal Health Services to $251 From $275, Maintains Buy Rating	MT
Nov. 25	Wells Fargo Adjusts Price Target on Universal Health Services to $230 From $285, Keeps Overweight Rating	MT

525d50c0.5_6MA1hKmDpGb8UOhRvWij9y5mOOY7FuoF-7BQrh4N8.l5ahUjc7_mw8BbZky0m98Hk2jzm8BNUdzDbsbkmsibekqsJVDhXXXyE4jA

Published financial data: UNIVERSAL HEALTH SERVICES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	11.38B	11.56B	12.64B	13.4B	14.28B
Total Revenues	11.38B	11.56B	12.64B	13.4B	14.28B
Cost of Goods Sold, Total	6.84B	6.9B	7.59B	8.24B	8.64B
Gross Profit	4.54B	4.66B	5.05B	5.16B	5.64B
Selling General & Admin Expenses, Total	108M	116M	119M	132M	141M
Depreciation & Amortization - (IS)	490M	510M	533M	582M	568M
Other Operating Expenses	2.63B	2.67B	3B	3.39B	3.76B
Other Operating Expenses, Total	3.22B	3.3B	3.66B	4.1B	4.47B
Operating Income	1.31B	1.36B	1.39B	1.06B	1.18B
Interest Expense, Total	-163M	-109M	-85.27M	-127M	-207M
Interest And Investment Income	469K	3.65M	3.3M	2.18M	2.47M
Net Interest Expenses	-163M	-105M	-81.97M	-125M	-205M
Income (Loss) On Equity Invest.	-	1.1M	6.2M	1.2M	874K
Other Non Operating Income (Expenses)	9.16M	2.07M	5.99M	-13.41M	-31.06M
EBT, Excl. Unusual Items	1.16B	1.26B	1.32B	924M	940M
Gain (Loss) On Sale Of Investments	4M	-4M	-	-	-
Asset Writedown	-97.63M	-	-14.39M	-57.55M	-
Other Unusual Items	-	-1M	-16.83M	-	-
EBT, Incl. Unusual Items	1.07B	1.25B	1.29B	866M	940M
Income Tax Expense	239M	299M	306M	209M	221M
Earnings From Continuing Operations	828M	953M	988M	657M	719M
Net Income to Company	828M	953M	988M	657M	719M
Minority Interest	-12.69M	-8.84M	3.96M	18.63M	-1.51M
Net Income - (IS)	815M	944M	992M	676M	718M
Preferred Dividend and Other Adjustments	2.03M	2.98M	2.06M	748K	308K
Net Income to Common Incl Extra Items	813M	941M	990M	675M	717M
Net Income to Common Excl. Extra Items	813M	941M	990M	675M	717M
Per Share Items
Net EPS - Basic	9.16	11.06	11.99	9.23	10.35
Basic EPS - Continuing Operations	9.16	11.06	11.99	9.23	10.35
Basic Weighted Average Shares Outstanding	88.76M	85.06M	82.52M	73.12M	69.32M
Net EPS - Diluted	9.13	10.99	11.82	9.14	10.23
Diluted EPS - Continuing Operations	9.13	10.99	11.82	9.14	10.23
Diluted Weighted Average Shares Outstanding	89.04M	85.59M	83.69M	73.83M	70.12M
Normalized Basic EPS	8.02	9.13	10.08	8.15	8.46
Normalized Diluted EPS	8	9.08	9.94	8.07	8.36
Dividend Per Share	0.6	0.2	0.8	0.8	0.8
Payout Ratio	6.5	1.84	6.65	8.65	7.73
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.8B	1.87B	1.93B	1.64B	1.74B
EBITA	1.31B	1.36B	1.39B	1.06B	1.18B
EBIT	1.31B	1.36B	1.39B	1.06B	1.18B
EBITDAR	1.91B	1.99B	2.05B	1.77B	1.88B
Total Revenues (As Reported)	11.38B	-	-	-	-
Effective Tax Rate - (Ratio)	22.39	23.9	23.64	24.16	23.51
Current Domestic Taxes	266M	312M	321M	212M	233M
Current Foreign Taxes	9.28M	13.98M	13.75M	14.74M	6.5M
Total Current Taxes	275M	326M	335M	227M	239M
Deferred Domestic Taxes	-38.18M	-24.5M	-31.06M	-16.04M	-21.32M
Deferred Foreign Taxes	1.87M	-2.5M	1.52M	-1.51M	3.37M
Total Deferred Taxes	-36.3M	-26.99M	-29.54M	-17.55M	-17.96M
Normalized Net Income	712M	777M	832M	596M	586M
Interest Capitalized	3.37M	4.26M	4.41M	8.6M	24.4M
Interest on Long-Term Debt	170M	113M	89.68M	136M	232M
Non-Cash Pension Expense	1.21M	-1.9M	-2M	-1.5M	-77K
Supplemental Operating Expense Items
Net Rental Expense, Total	108M	116M	119M	132M	141M
Imputed Operating Lease Interest Expense	34.58M	24.75M	19.48M	29.11M	49.13M
Imputed Operating Lease Depreciation	73.23M	91.31M	99.38M	103M	91.89M
Stock-Based Comp., Other (Total)	69.43M	65.9M	73.7M	85.3M	87.72M
Total Stock-Based Compensation	69.43M	65.9M	73.7M	85.3M	87.72M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	61.27M	1.22B	115M	103M	119M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	61.27M	1.22B	115M	103M	119M
Accounts Receivable, Total	1.56B	1.73B	1.75B	2.02B	2.24B
Total Receivables	1.56B	1.73B	1.75B	2.02B	2.24B
Inventory	160M	190M	207M	219M	217M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	134M	138M	195M	198M	237M
Total Current Assets	1.92B	3.28B	2.26B	2.54B	2.81B
Gross Property Plant And Equipment	9.43B	10.22B	11.14B	11.54B	12.21B
Accumulated Depreciation	-4.09B	-4.51B	-4.9B	-5.17B	-5.65B
Net Property Plant And Equipment	5.34B	5.71B	6.24B	6.37B	6.56B
Long-term Investments	139M	157M	184M	202M	170M
Goodwill	3.87B	3.88B	3.96B	3.91B	3.93B
Other Intangibles, Total	83.66M	82.59M	81.04M	78.1M	77.02M
Deferred Tax Assets Long-Term	16.19M	22.69M	45.71M	68.4M	85.63M
Deferred Charges Long-Term	6.37M	4.98M	6.52M	6.26M	6.97M
Other Long-Term Assets, Total	294M	335M	309M	319M	325M
Total Assets	11.67B	13.48B	13.09B	13.49B	13.97B
Liabilities
Accounts Payable, Total	447M	571M	659M	637M	614M
Accrued Expenses, Total	970M	1.1B	1.2B	1.12B	1.19B
Current Portion of Long-Term Debt	85.9M	330M	45.67M	78.4M	124M
Current Portion of Leases	58.09M	61.88M	67.22M	70.82M	74.65M
Current Income Taxes Payable	2.52M	44.42M	10.72M	4.61M	2.05M
Other Current Liabilities	-	376M	6K	2.4M	7.29M
Total Current Liabilities	1.56B	2.48B	1.98B	1.91B	2.01B
Long-Term Debt	3.88B	3.47B	4.07B	4.65B	4.72B
Long-Term Leases	286M	329M	381M	468M	452M
Pension & Other Post Retirement Benefits	17M	18M	20M	19M	22M
Deferred Tax Liability Non Current	25.07M	5.58M	-	-	-
Other Non Current Liabilities	313M	763M	445M	469M	562M
Total Liabilities	6.09B	7.07B	6.9B	7.52B	7.77B
Common Stock, Total	867K	851K	771K	710K	672K
Retained Earnings	5.47B	6.27B	6.06B	5.93B	6.14B
Comprehensive Income and Other	31.89M	48.12M	30.29M	-9.67M	9.29M
Total Common Equity	5.5B	6.32B	6.09B	5.92B	6.15B
Minority Interest	79.1M	89.39M	109M	49.46M	52.9M
Total Equity	5.58B	6.41B	6.2B	5.97B	6.2B
Total Liabilities And Equity	11.67B	13.48B	13.09B	13.49B	13.97B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	86.73M	85.09M	74.81M	70.67M	67.22M
ECS Total Common Shares Outstanding	86.71M	85.06M	77.09M	70.63M	67.18M
Book Value / Share	63.48	74.26	78.99	83.83	91.53
Tangible Book Value	1.55B	2.35B	2.05B	1.93B	2.14B
Tangible Book Value Per Share	17.88	27.65	26.54	27.37	31.85
Total Debt	4.31B	4.19B	4.56B	5.27B	5.37B
Net Debt	4.25B	2.97B	4.44B	5.17B	5.25B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-2.73M	-8.45M	-11.33M	-9.35M	-12.79M
Debt Equivalent Oper. Leases	862M	928M	951M	1.05B	1.13B
Minority Interest, Total (Incl. Fin. Div)	79.1M	89.39M	109M	49.46M	52.9M
Equity Method Investments, Total	6.4M	5.4M	9.4M	8.4M	7M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Others	160M	190M	207M	219M	217M
Land - (BS)	614M	665M	733M	727M	737M
Buildings, Total	5.65B	6.03B	6.51B	6.76B	7.14B
Machinery, Total	2.43B	2.61B	2.76B	2.94B	3.07B
Full Time Employees	67.7K	68.1K	68.3K	71.2K	73.35K
Part Time Employees	22.7K	20.9K	21.1K	22.6K	23.35K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	815M	944M	992M	676M	718M
Depreciation & Amortization - CF	490M	510M	533M	582M	568M
Depreciation & Amortization, Total	490M	510M	533M	582M	568M
(Gain) Loss From Sale Of Asset	-7.54M	1.96M	-5.17M	584K	-6.25M
Asset Writedown & Restructuring Costs	97.63M	-	14.39M	57.55M	-
Stock-Based Compensation (CF)	69.43M	65.84M	73.69M	85.38M	87.72M
Other Operating Activities, Total	12.69M	10.2M	12.87M	-18.63M	1.51M
Change In Accounts Receivable	-42.06M	-146M	-8.87M	-258M	-182M
Change In Income Taxes	-25.19M	9.59M	-54.03M	-29.51M	-43.45M
Change in Other Net Operating Assets	28.26M	964M	-674M	-98.48M	125M
Cash from Operations	1.44B	2.36B	884M	996M	1.27B
Capital Expenditure	-634M	-731M	-856M	-734M	-743M
Sale of Property, Plant, and Equipment	9.45M	8.17M	25.42M	12M	24.19M
Cash Acquisitions	-8M	-52.01M	-105M	-20.31M	-3.73M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-21.42M	-2.9M	19.73M	-	-
Investment in Marketable and Equity Securities, Total	-14.58M	-2.67M	-	-	-
Other Investing Activities, Total	-19.76M	-21.84M	1.46M	95.01M	-40.68M
Cash from Investing	-688M	-803M	-914M	-647M	-763M
Long-Term Debt Issued, Total	39.22M	802M	3.25B	705M	185M
Total Debt Issued	39.22M	802M	3.25B	705M	185M
Long-Term Debt Repaid, Total	-57.14M	-963M	-3.04B	-89.37M	-85.48M
Total Debt Repaid	-57.14M	-963M	-3.04B	-89.37M	-85.48M
Issuance of Common Stock	10.81M	12.32M	13.37M	14.07M	13.65M
Repurchase of Common Stock	-771M	-207M	-1.22B	-833M	-547M
Common Dividends Paid	-53M	-17.34M	-65.9M	-58.45M	-55.48M
Common & Preferred Stock Dividends Paid	-53M	-17.34M	-65.9M	-58.45M	-55.48M
Other Financing Activities, Total	-14.41M	-12.15M	-12.66M	-57.06M	-4.38M
Cash from Financing	-845M	-385M	-1.07B	-318M	-494M
Foreign Exchange Rate Adjustments	959K	739K	-499K	-8.42M	3.06M
Net Change in Cash	-94.02M	1.17B	-1.1B	21.9M	13.63M
Supplemental Items
Cash Interest Paid	157M	113M	75.61M	120M	200M
Cash Income Tax Paid (Refund)	261M	286M	363M	251M	258M
Levered Free Cash Flow	631M	1.09B	280M	125M	310M
Unlevered Free Cash Flow	733M	1.16B	334M	204M	440M
Change In Net Working Capital	-8.02M	-467M	309M	392M	208M
Net Debt Issued / Repaid	-17.92M	-161M	217M	616M	99.62M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	7.16	6.76	6.56	4.99	5.35
Return on Total Capital	8.48	8.29	8.16	6.03	6.44
Return On Equity %	14.97	15.89	15.67	10.8	11.82
Return on Common Equity	14.92	15.92	15.95	11.24	11.89
Margin Analysis
Gross Profit Margin %	39.88	40.3	39.95	38.53	39.5
SG&A Margin	0.95	1	0.94	0.98	0.99
EBITDA Margin %	15.85	16.18	15.25	12.26	12.21
EBITA Margin %	11.54	11.76	11.03	7.92	8.23
EBIT Margin %	11.54	11.76	11.03	7.92	8.23
Income From Continuing Operations Margin %	7.27	8.24	7.81	4.9	5.04
Net Income Margin %	7.16	8.17	7.84	5.04	5.03
Net Avail. For Common Margin %	7.14	8.14	7.83	5.04	5.02
Normalized Net Income Margin	6.26	6.72	6.58	4.45	4.1
Levered Free Cash Flow Margin	5.55	9.44	2.22	0.93	2.17
Unlevered Free Cash Flow Margin	6.44	10.03	2.64	1.52	3.08
Asset Turnover
Asset Turnover	0.99	0.92	0.95	1.01	1.04
Fixed Assets Turnover	2.23	2.09	2.12	2.12	2.21
Receivables Turnover (Average Receivables)	7.42	7.03	7.27	7.12	6.71
Inventory Turnover (Average Inventory)	44.4	39.4	38.22	38.73	39.68
Short Term Liquidity
Current Ratio	1.23	1.32	1.14	1.33	1.4
Quick Ratio	1.04	1.19	0.94	1.11	1.17
Operating Cash Flow to Current Liabilities	0.92	0.95	0.45	0.52	0.63
Days Sales Outstanding (Average Receivables)	49.19	52.08	50.17	51.27	54.38
Days Outstanding Inventory (Average Inventory)	8.22	9.29	9.55	9.42	9.2
Average Days Payable Outstanding	23.77	26.86	29.49	28.66	26.42
Cash Conversion Cycle (Average Days)	33.63	34.51	30.23	32.03	37.16
Long Term Solvency
Total Debt/Equity	77.21	65.47	73.56	88.3	86.53
Total Debt / Total Capital	43.57	39.57	42.38	46.89	46.39
LT Debt/Equity	74.63	59.35	71.74	85.8	83.33
Long-Term Debt / Total Capital	42.11	35.87	41.33	45.56	44.68
Total Liabilities / Total Assets	52.15	52.46	52.66	55.76	55.6
EBIT / Interest Expense	8.05	12.46	16.35	8.34	5.67
EBITDA / Interest Expense	11.71	18.2	24	13.94	9.09
(EBITDA - Capex) / Interest Expense	7.83	11.5	13.96	8.18	5.51
Total Debt / EBITDA	2.25	2.11	2.23	2.97	2.85
Net Debt / EBITDA	2.22	1.5	2.17	2.91	2.78
Total Debt / (EBITDA - Capex)	3.37	3.34	3.83	5.07	4.7
Net Debt / (EBITDA - Capex)	3.33	2.37	3.73	4.97	4.6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.63	1.59	9.37	5.99	6.59